00110-V |
HIV_1 tat recombinant antigen full length 15 kDa |
100 µg |
359.52 € |
- |
Virogen |
00111-V |
HIV_1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV_1 gag region 39 kDa |
100 µg |
359.52 € |
- |
Virogen |
00112-V |
HIV_1 nef recombinant antigen a.a 3 to a.a 190 of the HIV_1 nef region 20 kDa |
100 µg |
359.52 € |
- |
Virogen |
00113-V |
HIV_1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV_1 env region 32 kDa |
100 µg |
359.52 € |
- |
Virogen |
00114-V |
HIV _2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV_2 env region 34 kDa |
100 µg |
359.52 € |
- |
Virogen |
00115-V |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
100 µg |
359.52 € |
- |
Virogen |
00115-V-B |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
100 µg |
389.05 € |
- |
Virogen |
00115-V-F |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
100 µg |
389.05 € |
- |
Virogen |
00115-V-R |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
100 µg |
389.05 € |
- |
Virogen |
00116-V |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
100 µg |
359.52 € |
- |
Virogen |
00116-V-B |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
100 µg |
389.05 € |
- |
Virogen |
00116-V-F |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
100 µg |
389.05 € |
- |
Virogen |
00116-V-R |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
100 µg |
389.05 € |
- |
Virogen |
00117-V |
HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
100 µg |
359.52 € |
- |
Virogen |
00120-V |
HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa |
100 µg |
358.24 € |
- |
Virogen |
00121-V |
HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa |
100 µg |
359.52 € |
- |
Virogen |
00122-V |
HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant |
100 µg |
359.52 € |
- |
Virogen |
00123-V |
HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
100 µg |
359.54 € |
- |
Virogen |
00124-V |
HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
100 µg |
359.52 € |
- |
Virogen |
00131-V |
HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. |
100 µg |
359.52 € |
- |
Virogen |
00132-V |
HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. |
100 µg |
359.54 € |
- |
Virogen |
00133-V |
HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. |
100 µg |
359.52 € |
- |
Virogen |
00141-V |
T. Pallidum recombinant antigen p15 (full length) |
100 µg |
359.52 € |
- |
Virogen |
00142-V |
T. Pallidum recombinant antigen p17 (full length) |
100 µg |
359.54 € |
- |
Virogen |
00143-V |
T. Pallidum recombinant antigen p45 (full length) |
100 µg |
359.52 € |
- |
Virogen |
00144-V |
T. Pallidum recombinant antigen TmpA (full length) |
100 µg |
359.52 € |
- |
Virogen |
00150-V |
HCV core 2_119aa recombinant antigen. Genotypes available 1a, 1b, 2a, 2b, 3a, 3b, 3_10, 4, 5, 6a |
100 µg |
359.52 € |
- |
Virogen |
00151-V |
HCV core 24 antigen. |
100 µg |
359.52 € |
- |
Virogen |
00152-V |
HCV core recombinant antigen a.a.105_302 |
100 µg |
359.54 € |
- |
Virogen |
00153-V |
HCV NS3 1192_1456aa recombinant antigen a.a.1192_1459. Available genotypes 1a, 1b, 2b, 2c, 5, 6a |
100 µg |
359.52 € |
- |
Virogen |
00154-V |
HCV NS3 1359_1456aa antigen. The protein contains immunodominant regions (1359_1456aa). available genotypes 1a, 1b, 2b, 3, 4, 5, 6 |
100 µg |
359.52 € |
- |
Virogen |
00155-V |
HCV NS4 mosaic recombinant antigen a.a1691_1710, 1712_1733, 1921_1940. Genotypes available 1, 2, 3, 5. |
100 µg |
359.54 € |
- |
Virogen |
00156-V |
HCV NS4 1916_1947aa recombinant antigen. |
100 µg |
359.52 € |
- |
Virogen |
00157-V |
HCV NS5 2061_2302aa recombinant antigen. |
100 µg |
359.52 € |
- |
Virogen |
00158-V |
HCV NS5 2212_2313aa recombinant antigen. Available genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. |
100 µg |
359.52 € |
- |
Virogen |
00159-V |
HAV VP1_P2A recombinant antigen a.a. 722_830. |
100 µg |
359.52 € |
- |
Virogen |
00160-V |
HAV VP4_VP2 recombinant antigen a.a. 55_164. |
100 µg |
359.52 € |
- |
Virogen |
00161-V |
HAV P2C_P3A recombinant antigen a.a. 1492_1606. |
100 µg |
359.52 € |
- |
Virogen |
00162-V |
HAV P3C recombinant antigen a.a. 1643_1743. |
100 µg |
359.54 € |
- |
Virogen |
00163-V |
HAV VP3 recombinant antigen a.a. 304_415. |
100 µg |
359.52 € |
- |
Virogen |
00164-V |
HAV VP1_P2A recombinant antigen a.a. 669_782. |
100 µg |
359.52 € |
- |
Virogen |
00165-V |
HAV HAV P2C recombinant antigen a.a. 1121_1234. |
100 µg |
359.52 € |
- |
Virogen |
00166-V |
HAV P2C_P3A recombinant antigen a.a. 1392_1521. |
100 µg |
359.52 € |
- |
Virogen |
00167-V |
HDV Ag recombinant antigen |
100 µg |
359.52 € |
- |
Virogen |
00168-V |
HIV_1 p17_24_gp120_gp41 recombinant antigen. |
100 µg |
359.54 € |
- |
Virogen |
00169-V |
HIV_1 p17_24_gp120 antigen.The protein contains the HIV immunodominant regions from gag p17_p24 gp 120. |
100 µg |
359.54 € |
- |
Virogen |
00170-V |
HIV_1 gp41 recombinant antigen. |
100 µg |
359.54 € |
- |
Virogen |
00171-V |
HIV_1 gp41 Long recombinant antigen. |
100 µg |
359.54 € |
- |
Virogen |
00172-V |
HIV_1 p17_p24 recombinant antigen. |
100 µg |
359.52 € |
- |
Virogen |
00173-V |
HIV_2 gp32 recombinant antigen. . |
100 µg |
359.54 € |
- |
Virogen |
00174-V |
HIV_1 p24 recombinant antigen. |
100 µg |
359.54 € |
- |
Virogen |
00175-V |
HIV 1, 2 envelope recombinant antigen. HIV_1 envelope conjugated to HIV_2 envelope peptide. |
100 µg |
359.54 € |
- |
Virogen |
00176-V |
HIV 1 envelope recombinant antigen. HIV_1 evnelope protein spanning the C_Terminus of gp 120 and most of gp 41. |
100 µg |
359.54 € |
- |
Virogen |
00177-V |
HIV 1 p24 core recombinant antigen. |
100 µg |
359.52 € |
- |
Virogen |
00178-V |
HIV type O envelope antigen. Synthetic HIV type_O peptide, containing the HIV type_O envelope_derived sequence. |
100 µg |
359.52 € |
- |
Virogen |
00179-V |
HIV _2 env gp36 recombinant antigen. a.a 390 to a.a 702. |
100 µg |
359.52 € |
- |
Virogen |
00180-V |
HIV 2 gp36 envelope antigen. Synthetic HIV_2 Peptide containing the HIV_2 specific sequence of gp36. |
100 µg |
359.54 € |
- |
Virogen |
00181-V |
HSV_1 gD recombinant antigen a.a. 266_394. |
100 µg |
359.52 € |
- |
Virogen |
00182-V |
HSV_2 gD recombinant antigen a.a. 266_394. |
100 µg |
359.54 € |
- |
Virogen |
00183-V |
HSV_2 gD recombinant antigen a.a. 525_578. |
100 µg |
359.54 € |
- |
Virogen |
00184-V |
HSV_1 gD recombinant antigen a.a. 84_175. |
100 µg |
359.54 € |
- |
Virogen |
00185-V |
CMV Pp65 (UL83) recombinant antigen (full length) |
100ug |
297.89 € |
- |
Virogen |
00186-V |
CMV Pp150 recombinant antigen |
100ug |
297.89 € |
- |
Virogen |
00187-V |
CMV gB-AD1 (UL55) recombinant antigen |
100ug |
297.89 € |
- |
Virogen |
00188-V |
CMV Pp65 (UL83) recombinant antigen a.a. 297_510 |
100 µg |
359.54 € |
- |
Virogen |
00189-V |
CMV Pp52 (UL44) recombinant antigen |
100ug |
297.89 € |
- |
Virogen |
00191-V |
SARS_Associated Coronavirus E recombinant antigen a.a. 1_76. |
100 µg |
359.54 € |
- |
Virogen |
00192-V |
SARS_Associated Coronavirus Nucleocapsid recombinant antigen N a.a. 1_49. |
100 µg |
359.54 € |
- |
Virogen |
00193-V |
SARS_Associated Coronavirus Nucleocapsid recombinant antigen C a.a. 340_390. |
100 µg |
359.54 € |
- |
Virogen |
00194-V |
SARS_Associated Coronavirus M recombinant antigen a.a. 182_216. |
100 µg |
359.54 € |
- |
Virogen |
00195-V |
SARS_Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12_53_90_115_171_203. |
100 µg |
359.52 € |
- |
Virogen |
00196-V |
SARS_Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408_470_540_573. |
100 µg |
359.54 € |
- |
Virogen |
00197-V |
SARS_Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051_1076_1121_1154_1162_1190. |
100 µg |
359.52 € |
- |
Virogen |
00198-V |
HIV_1 reverse transcriptase recombinant antigen. |
100 µg |
359.52 € |
- |
Virogen |
00199-V |
HIV_1 intergase antigen. The protein contains the HIV_1 immunodominant regions from pol protein (integrase). |
100 µg |
359.54 € |
- |
Virogen |
00200-V |
VZV gE recombinant antigen a.a. 48_135. |
100 µg |
359.52 € |
- |
Virogen |
00201-V |
VZV ORF9 recombinant antigen a.a. 6_28_76_100. |
100 µg |
359.52 € |
- |
Virogen |
00202-V |
VZV ORF26 recombinant antigen a.a. 9_33_184_208. |
100 µg |
359.54 € |
- |
Virogen |
00203-V |
HLTV_I envelope recombinant antigen. C_terminus of gp_46 and most of p21. |
100 µg |
359.54 € |
- |
Virogen |
00204-V |
HLTV_I p24 core recombinant antigen. |
100 µg |
359.52 € |
- |
Virogen |
00205-V |
HTLV_1 virus mosaic recombinant antigen a.a. 374_400_190_207. |
100 µg |
359.54 € |
- |
Virogen |
00206-V |
Toxoplasma gondii MIC 3 recombinant antigen |
100 µg |
359.54 € |
- |
Virogen |
00207-V |
Toxoplasma gondii P24 (GRA1) recombinant antigen |
100 µg |
359.52 € |
- |
Virogen |
00208-V |
Toxoplasma gondii P29 (GRA7) recombinant antigen |
100 µg |
359.52 € |
- |
Virogen |
00209-V |
Toxoplasma gondii P30 (SAG1) recombinant antigen |
100 µg |
359.52 € |
- |
Virogen |
00211-V |
HHV_4 recombinant p18 antigen Region 1_119aa |
100 µg |
359.52 € |
- |
Virogen |
00212-V |
HHV_4 recombinant mosaic EBNA1 antigen. Region 1_90_408_498aa |
100 µg |
359.54 € |
- |
Virogen |
00213-V |
HHV_4 recombinant EA antigen. Region 306_390aa |
100 µg |
359.54 € |
- |
Virogen |
00214-V |
Tick_born encephalitis virus gE recombinant antigen |
100 µg |
359.52 € |
- |
Virogen |
00215-V |
Rubella virus E1 mosaic recombinant antigen a.a. 157_176_374_390_213_239. |
100 µg |
359.52 € |
- |
Virogen |
00216-V |
Rubella virus E2 recombinant antigen a.a. 31_105. |
100 µg |
359.52 € |
- |
Virogen |
00217-V |
Rubella virus capsid (C) recombinant antigen a.a. 1_123. |
100 µg |
359.52 € |
- |
Virogen |
00401-V |
West Nile Virus Envelope recombinant antigen_Immunodominant region |
100 µg |
359.52 € |
- |
Virogen |
00402-V |
West Nile Virus Pre_M recombinant antigen_Immunodominant region |
100 µg |
359.54 € |
- |
Virogen |
00403-V |
West Nile Virus Envelope full length recombinant antigen 42 kDa region |
100 µg |
359.54 € |
- |
Virogen |
00700-V |
HTLV_1 gp21 recombinant protein |
100 µg |
359.54 € |
- |
Virogen |
00701-V |
HTLV_1 gp46 recombinant protein |
100 µg |
359.54 € |
- |
Virogen |
00900-V |
Allergens, Phospholipase A2 P00630 Bee Venom Recombinant Protein |
100ug/vial |
277.34 € |
- |
Virogen |
00901-V |
Allergens, Soy Bean p34 Recombinant protein |
100ug/vial |
277.73 € |
- |
Virogen |
011-A |
anti_GSK3 Beta IgG2a (monoclonal). Produced against a recombinant Xenopus laevis protein. |
100 µg |
359.52 € |
- |
Virogen |
0114-A |
anti_HIV_2 gp36 IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.52 € |
- |
Virogen |
0116-A |
anti_HCV core IgG1 (monoclonal) Produced against a recombinant, HCV core 00115_V, protein. |
100 µg |
359.54 € |
- |
Virogen |
0117-A |
anti_HCV core IgG2a (monoclonal) Produced against a recombinant, HCV core 00115_V, protein. |
100 µg |
359.54 € |
- |
Virogen |
012-A |
anti_HIV_1 p24 IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.54 € |
- |
Virogen |
013-A |
anti_HIV_1 p55_17 IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.52 € |
- |
Virogen |
014-A |
anti_HIV_1 p17 IgG1 (monoclonal) Produced against a recombinant protein |
100 µg |
359.52 € |
- |
Virogen |
015-A |
anti_HIV_1 gp41 IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.54 € |
- |
Virogen |
016-A |
anti_HCV core IgG2a (monoclonal) Produced against a recombinant protein. |
100 µg |
359.54 € |
- |
Virogen |
017-A |
anti_HCV core IgG2a (monoclonal) Produced against a recombinant protein. |
100 µg |
359.54 € |
- |
Virogen |
018-A |
anti_HCV NS4 IgG2a (monoclonal) Produced against a recombinant protein. |
100 µg |
359.52 € |
- |
Virogen |
019-A |
anti_FAS IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.52 € |
- |
Virogen |
020-A |
anti_HSV (I) gD IgG1 (monoclonal) Produced against a HSV (I) viral concentrate |
100 µg |
359.52 € |
- |
Virogen |
021-A |
anti_HSV (II) gB IgG1 (monoclonal) Produced against a HSV (II) infected cells. |
100 µg |
359.54 € |
- |
Virogen |
022-A |
anti_HCMV IE pp72 IgG2a (monoclonal) Produced against a HCMV IE concentrate. |
100 µg |
359.52 € |
- |
Virogen |
023-A |
anti_HCMV IE pp65 IgG1 (monoclonal) Produced against a HCMV infected cells. |
100 µg |
359.52 € |
- |
Virogen |
024-A |
anti_HCMV gB IgG1 (monoclonal) Produced against a HCMV infected cells. |
100 µg |
359.52 € |
- |
Virogen |
025-A |
anti_Adenovirus E11 IgG2a (monoclonal) Produced against purified Ad1 virus |
100 µg |
359.52 € |
- |
Virogen |
026-A |
anti_Adenovirus C11 IgG2a (monoclonal) Produced against purified Ad7 virus |
100 µg |
359.54 € |
- |
Virogen |
027-A |
anti_Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. |
100 µg |
359.54 € |
- |
Virogen |
028-A |
anti_TGE IgG1 (monoclonal) Produced against purified TGE virus 1E11. |
100 µg |
359.54 € |
- |
Virogen |
029-A |
anti_FAS IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.54 € |
- |
Virogen |
030-A |
anti-HBcAg core IgM (monoclonal) |
100ug |
297.89 € |
- |
Virogen |
031-A |
anti_HBsAg pre_surface IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. |
100 µg |
359.52 € |
- |
Virogen |
032-A |
anti_HBsAg surface antigen IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. |
100 µg |
359.54 € |
- |
Virogen |
033-A |
anti_HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope 70 – 80 a.a. |
100 µg |
359.54 € |
- |
Virogen |
034-A |
anti_HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope 135_140 a.a. |
100 µg |
359.54 € |
- |
Virogen |
035-A |
anti_HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope 141_154 a.a. |
100 µg |
359.54 € |
- |
Virogen |
036-A |
anti_HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope 1_10 a.a. |
100 µg |
359.54 € |
- |
Virogen |
037-A |
anti_HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope 138_ 145 a.a. |
100 µg |
359.52 € |
- |
Virogen |
038-A |
anti_HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope 130_140 a.a. |
100 µg |
359.54 € |
- |
Virogen |
039-A |
anti_FAS IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.54 € |
- |
Virogen |
041-A |
anti-Thyroxine monoclonal antibody IgG2a |
100ug |
297.89 € |
- |
Virogen |
049-A |
anti_FAS IgM (monoclonal) |
100 µg |
359.54 € |
- |
Virogen |
059-A |
anti_SLAM anti_CDw150 IgG2a (monoclonal) Produced against an activated B cell line. |
100 µg |
359.54 € |
- |
Virogen |
060-A |
anti_CD3 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
061-A |
anti_CD4 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
062-A |
anti_CD8 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
063-A |
anti_CD16 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
064-A |
anti_CD20 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
065-A |
anti_CD22 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
066-A |
anti_p53, clone BP53_12 |
100 µg |
359.54 € |
- |
Virogen |
067-A |
anti_CD45 RA IgG2 monoclonal antibody |
100 µg |
359.52 € |
- |
Virogen |
068-A |
anti_CD54 IgG2b_k monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
069-A |
anti_CD37 IgG2b (monoclonal) Produced against a B cell line. |
100 µg |
359.54 € |
- |
Virogen |
071-A |
anti_CD19 IgG1 monoclonal antibody |
100 µg |
359.52 € |
- |
Virogen |
079-A |
anti_Nuclear Antigen (Proliferating Cells) IgM (monoclonal) Produced against a proliferating Harvey cell line. |
100 µg |
359.54 € |
- |
Virogen |
089-A |
anti_CD66e IgG1 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
101-A |
anti_Glutathione monoclonal antibody IgG1 |
100 µg |
277.34 € |
- |
Virogen |
102-A |
anti_Cysteine monoclonal antibody IgG1 |
100 µg |
359.54 € |
- |
Virogen |
131-A |
anti_RhoD human antigen IgG1 |
100 µg |
359.54 € |
- |
Virogen |
132-A |
anti_A1, A2 human blood antigen IgM |
100 µg |
359.52 € |
- |
Virogen |
133-A |
anti_A1, A2, A3 human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
134-A |
anti_B human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
135-A |
anti_AB human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
136-A |
anti_Rh(o)D human antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
137-A |
anti_Rh(o)D and Rh(o)Dii human Rhesus system antigen IgG1 |
100 µg |
359.54 € |
- |
Virogen |
138-A |
anti_RhoC human Rhesus system antigen IgM |
100 µg |
359.52 € |
- |
Virogen |
139-A |
anti_A1, A2 human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
140-A |
anti_B human blood group antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
141-A |
anti_H n_ab human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
142-A |
anti_H ab human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
143-A |
anti_H inh human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
144-A |
anti_M human blood antigen IgM |
100 µg |
359.52 € |
- |
Virogen |
145-A |
anti_N human blood antigen Ig2b |
100 µg |
359.54 € |
- |
Virogen |
146-A |
Antiglobulin (COOMBS) Rabbit polyclonal |
100 µg |
359.54 € |
- |
Virogen |
199-A |
anti_HCV NS5a rabbit (polycnonal) Produced against a recombinant protein |
100 µg |
359.54 € |
- |
Virogen |
216-A |
anti_HCV core IgG1 (monoclonal)Produced against recombinant antigen |
100 µg |
359.54 € |
- |
Virogen |
245-A |
anti_HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 |
100 µg |
359.54 € |
- |
Virogen |
246-A |
anti_HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen |
100 µg |
359.54 € |
- |
Virogen |
247-A |
anti_HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 |
100 µg |
359.54 € |
- |
Virogen |
266-A |
anti_HCV NS5b rabbit (polycnonal)Produced against a recombinant protein |
100 µg |
359.54 € |
- |
Virogen |
276-A |
anti_HCV NS5a rabbit polyclonal antibody directed against genotype 2A |
100 µg |
359.54 € |
- |
Virogen |
3001-V |
Prostatic pacid hosphatase _ full length (human) |
100 ug/vial |
289.46 € |
- |
Virogen |
3002-V |
Ovine Prolactin |
100 ug/vial |
289.46 € |
- |
Virogen |
501-A |
anti_CD3 T_cell |
100 µg |
359.54 € |
- |
Virogen |
502-A |
anti_CD4 T helper cells |
100 µg |
359.52 € |
- |
Virogen |
503-A |
anti_CD5 All T_cells |
100 µg |
359.52 € |
- |
Virogen |
504-A |
anti_CD7 All T_cells |
100 µg |
359.54 € |
- |
Virogen |
505-A |
anti_CD8 T cytotoxic_supressor cells |
100 µg |
359.54 € |
- |
Virogen |
506-A |
anti_CD10 Lymphoblasts |
100 µg |
359.52 € |
- |
Virogen |
507-A |
anti_CD16 NK_cells, monocytes, granulocytes |
100 µg |
359.52 € |
- |
Virogen |
508-A |
anti_CD18 Leucocytes |
100 µg |
359.52 € |
- |
Virogen |
509-A |
anti_CD20 B_lymphocytes |
100 µg |
359.54 € |
- |
Virogen |
510-A |
anti_CD22 B_lymphocytes |
100 µg |
359.54 € |
- |
Virogen |
511-A |
anti_CD25 IL_2 receptor expressed on activated T and B cells |
100 µg |
359.54 € |
- |
Virogen |
512-A |
anti_CD26 Activated T, B lymphocytes and macrophages |
100 µg |
359.54 € |
- |
Virogen |
513-A |
anti_CD34 Hematopoietic precursor cells |
100 µg |
359.52 € |
- |
Virogen |
514-A |
anti_CD38 Hematopoietic precursors, thymocytes, activated T_cells, plasma cells |
100 µg |
359.54 € |
- |
Virogen |
515-A |
anti_CD45 Leukocytes |
100 µg |
359.52 € |
- |
Virogen |
516-A |
anti_CD45 RA B_cells, T_cells, NK_cells |
100 µg |
359.54 € |
- |
Virogen |
517-A |
anti_ICAM_3, Leukocytes |
100 µg |
359.54 € |
- |
Virogen |
518-A |
anti_Transferrin receptor on activated T_B_, cells |
100 µg |
359.54 € |
- |
Virogen |
519-A |
anti_FAS antigen |
100 µg |
359.54 € |
- |
Virogen |
520-A |
anti_HLA_DR |
100 µg |
359.54 € |
- |
Virogen |
521-A |
anti_HLA_ABC on all Leukocytes |
100 µg |
359.54 € |
- |
Virogen |
522-A |
anti_IgM Heavy chain expressed on B cells |
100 µg |
359.54 € |
- |
Virogen |
523-A |
anti_Cortical thymocytes |
100 µg |
359.54 € |
- |
Virogen |
900-V |
Allergens, Dermatophagoides farina Der F1 antigen (recombinant). Full length. Non enzymatically active. |
100ug/vial |
277.73 € |
- |
Virogen |
901-V |
Allergens, Dermatophagoides pteronyssinus Der P1 antigen . Full length. Non enzymatically active. |
100ug/vial |
277.34 € |
- |
Virogen |